How has been the historical performance of Niva Bupa Health?

Answer:The historical performance of Niva Bupa Health shows significant growth in its financial metrics from March 2024 to March 2025.

Breakdown:
In the standalone annual results, Niva Bupa Health reported net sales of 4,894.46 Cr in March 2025, up from 3,811.25 Cr in March 2024, indicating a strong revenue increase. Other operating income also rose to 479.82 Cr from 304.22 Cr, leading to a total operating income of 5,374.28 Cr compared to 4,115.47 Cr the previous year. Total expenditure, excluding depreciation, increased to 5,316.18 Cr from 4,254.40 Cr, with notable rises in employee costs and manufacturing expenses. Operating profit (PBDIT) improved significantly to 213.52 Cr from 81.85 Cr, and profit before tax mirrored this positive trend, reaching 213.52 Cr from 81.85 Cr. Consequently, profit after tax also increased to 213.52 Cr from 81.85 Cr, resulting in an earnings per share (EPS) of 1.17, up from 0.48. The operating profit margin improved to 1.19% from -3.65%, while the PAT margin rose to 4.36% from 2.15%. Cash flow from operating activities was strong at 812.00 Cr, and the closing cash and cash equivalents increased to 142.00 Cr from 101.00 Cr, reflecting a positive cash position. Overall, Niva Bupa Health demonstrated robust growth across key financial metrics in the reported period.